"It doesn't work that way." Instead, Ghen said patients should undergo comprehensive testing before considering peptide therapy, including hormone panels, inflammatory markers, metabolic testing and, in some cases, mitochondrial or autonomic nervous system evaluations
The short answer is that only tesamorelin has undergone human clinical trials and has received FDA approval for an extremely limited purpose
To maximize benefits and ensure safety, experts suggest a holistic approach: Nutrition: Adequate protein (1.62.0 g/kg body weight) and micronutrients are essential for effective protein synthesis
Animal studies have indicated that GHRH agonists may reduce myocardial infarct scarring in swine [8]
- Administration: Subcutaneous injection, preferably on an empty stomach
Its commonly described as a selective agonist at the ghrelin or growth hormone secretagogue receptor, which means it acts more like a precise switch than a broad hormonal flood